Compare IXHL & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IXHL | DOMH |
|---|---|---|
| Founded | 2001 | 1967 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.0M | 47.2M |
| IPO Year | 2024 | 2010 |
| Metric | IXHL | DOMH |
|---|---|---|
| Price | $3.63 | $3.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 459.9K | 127.1K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 21.10% |
| EPS Growth | N/A | ★ 34.03 |
| EPS | ★ N/A | N/A |
| Revenue | $12,000.00 | ★ $123,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $0.11 | $2.69 |
| 52 Week High | $6.39 | $8.40 |
| Indicator | IXHL | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 51.40 |
| Support Level | $0.34 | $2.77 |
| Resistance Level | $3.68 | $3.52 |
| Average True Range (ATR) | 0.34 | 0.23 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 88.72 | 50.99 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.